Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sollis Therapeutics, Inc.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject who have successfully completed all STX-015-18-01 study related activities, are reconfirmed to be eligible and have signed informed consent to participate.
You may not be if
Subjects who, in the opinion of the investigator, have demonstrated significant non-compliance with STX-015-18-01 study procedures.
Subjects who were unblinded to their treatment in STX-015-18-01 study.
Clareo Health | Long-Term Follow-up Safety of Clonidine Micropellets
